The future of HIV care - long term remission and eliminating co-morbidities [ 2018 - 2022 ]

Research Grant

[Cite as]

Researchers: Prof Sharon Lewin (Principal investigator)

Brief description Despite the great successes in antiretroviral therapy (ART) in reducing HIV-associated mortality, treatment is life long and there is no cure. The major barrier to a cure for HIV is the persistence of long lived latently infected cells on ART. Over the next five years I will discover, develop, optimise and evaluate novel interventions to eliminate latently infected cells, long lived infected cells in the liver and enhance HIV-specific immunity through immunotherapy.

Funding Amount $AUD 585,269.15

Funding Scheme Practitioner Fellowships

Notes Practitioner Fellowship

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]